Pfizer Inc
Inventory futures are flat immediately after Dow notches best thirty day period because January
Traders function on the ground of the New York Stock Exchange. NYSE U.S. inventory futures ended up flat in overnight investing Sunday right after the significant averages logged gains for April, and the Dow Jones Industrial Ordinary notched its very best thirty day period considering the fact that January. Futures tied to the Dow dipped […]
Read More
Obesity is a chronic disease. It’s why treating it will be so profitable unless payers push back
While there has been plenty of buzz about how successful patients have been in losing weight while taking a new class of obesity medications, there is a growing realization that when people stop taking these pricey drugs, the pounds can creep back on. There was a frank discussion of this on Eli Lilly’s first-quarter earnings […]
Read More
Merck revenue falls after dramatic drop in sales of Covid antiviral treatment
Medicine pill is seen with Merck logo displayed on a screen in the background in this illustration photo taken in Poland on October 4, 2021. NurPhoto | NurPhoto | Getty Images Merck on Thursday reported first-quarter revenue that fell 9% from the same period a year ago largely due to a steep drop in sales […]
Read More
Abbott Labs shares pop as revenue, earnings defy steep drop in Covid test sales
The Abbott manufacturing facility in Sturgis, Michigan, on May 13, 2022. Jeff Kowalsky | AFP | Getty Images Shares of Abbott Laboratories popped Wednesday after the company’s earnings and revenue topped Wall Street’s expectations, defying a dramatic slowdown in sales of its Covid-19 tests. The medical products company posted adjusted earnings per share of $1.03. […]
Read More
Johnson & Johnson expects no new Covid vaccine revenue, after shots drive earnings beat
The Janssen Johnson & Johnson COVID-19 vaccine. Allen J. Schaben | Los Angeles Times | Getty Images International Covid vaccine sales helped spark Johnson & Johnson‘s revenue and earnings beat on Tuesday, but the company said it expects no sales from the shot moving forward. “Regarding our Covid-19 vaccine, we do not anticipate material sales […]
Read More
FDA authorizes additional omicron Covid booster for seniors and people with weak immune systems
Sylvester Fisher gets a influenza vaccine from pharmacist Patricia Pernal during an event hosted by the Chicago Department of Public Health at the Southwest Senior Center on September 09, 2022 in Chicago, Illinois. The vaccines were being offered along with pneumonia vaccines and the recently authorized COVID-19 booster vaccine, which protects against the original SARS-CoV-2 […]
Read More
Goldman says dividend expansion shares will outperform beneath existing situations. 10 names it endorses
Goldman Sachs claims one profits-targeted system is off to a potent begin this year, and will continue on to outperform – dividend development stocks. S & P 500 dividends grew by 8% 12 months around yr in the first quarter of 2023, according to a Friday be aware. On the other hand, buybacks dropped by […]
Read More
Pfizer CEO signs letter in support of FDA after federal judge suspends approval of abortion pill
Pfizer Chairman and CEO Albert Bourla attends a conversation during the World Economic Forum WEF 2022 Annual Meeting in Davos, Switzerland, May 25, 2022. Zheng Huansong | Xinhua News Agency | Getty Images Pfizer‘s CEO signed on to an industry letter in support of the Food and Drug Administration’s authority to regulate drugs after a […]
Read More
Pfizer RSV vaccine for older adults should be monitored for nervous system condition Guillain-Barre, scientists say
A health worker prepares a flu vaccine shot before administering it to a local resident in Los Angeles, the United States, on Dec. 17, 2022. Xinhua News Agency | Getty Images People who receive Pfizer‘s RSV vaccine for older adults should be monitored for Guillain-Barre syndrome, after two people developed the nervous system disorder after […]
Read More
J&J backs out of RSV vaccine race with rivals Pfizer and GSK
A Johnson & Johnson building is shown in Irvine, California. Mike Blake | Reuters Johnson & Johnson on Wednesday said it’s ducking out of the RSV vaccine race, weeks after competitors Pfizer and GSK inched closer to launching the world’s first shot against the deadly virus. J&J will stop working on its investigational RSV adult […]
Read More